Yusheng Lu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CD266+ myofibroblasts mediate resistance to immunochemotherapy through ECM stiffness in head and neck squamous cell carcinoma.
Journal: Cancer immunology research
Published: November 04, 2025
Pembrolizumab With Anlotinib in Advanced Oral Mucosal Melanoma: A Retrospective Trial.
Journal: Oral diseases
Published: August 06, 2025
IL-4-STAT6-induced high Siglec-G/10 expression aggravates the severe immune suppressive tumor microenvironment and impedes the efficacy of immunotherapy in head and neck squamous cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: May 19, 2025
MOF-derived novel porous Fe3O4@C nanocomposites as smart nanomedical platforms for combined cancer therapy: magnetic-triggered synergistic hyperthermia and chemotherapy.
Journal: Journal of materials chemistry. B
Published: August 29, 2020
TLR4 activation leads to anti-EGFR therapy resistance in head and neck squamous cell carcinoma.
Journal: American journal of cancer research
Published: November 08, 2019
A novel IFNα-induced long noncoding RNA negatively regulates immunosuppression by interrupting H3K27 acetylation in head and neck squamous cell carcinoma.
Journal: Molecular cancer
Published: October 02, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026